Raqia Therapeutics is an exciting startup company developing a transformative chimeric antigen receptor (CAR) technology for immunotherapy. At Raqia Therapeutics, they are motivated to bring life-changing therapy to patients with cancer.

Biotechnology

Raqia Therapeutics

Fred Mermelstein

John Newcomb

Jun Ren

Alberto Nobili

Stephanie Kwei

Julia A. Novina

The Leadership Team at Raqia Therapeutics is responsible for setting the strategic direction and vision of the company, guiding the development of innovative CAR technology for cancer immunotherapy. They oversee key operational areas, including scientific research, legal compliance, and corporate governance, ensuring that Raqia Therapeutics remains focused on delivering transformative therapies to patients effectively and ethically.

Leadership Team

Research and Development

Leadership Team

About

Team members

Other teams at Raqia Therapeutics

Research and Development